2014
DOI: 10.1016/j.jcjo.2014.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of ocular metastasis with anti-VEGF: A literature review and case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 22 publications
0
13
0
Order By: Relevance
“…Although much of the literature reports satisfying local remission, there are many cases of failure. [ 16 , 17 ] In general, CM arising from BC often indicates a poor prognosis with an average survival time of 7 to 32 months. [ 18 ]…”
Section: Discussionmentioning
confidence: 99%
“…Although much of the literature reports satisfying local remission, there are many cases of failure. [ 16 , 17 ] In general, CM arising from BC often indicates a poor prognosis with an average survival time of 7 to 32 months. [ 18 ]…”
Section: Discussionmentioning
confidence: 99%
“…Intravitreal bevacizumab has been recently reported to be an optional treatment for choroidal metastasis when systemic chemotherapy and radiation therapy fail. 11 One of the contraindication of systemic bevacizumab is the development of necrotic hemorrhages which can cause uncontrolled hemoptysis. As best we know, there has not been any reports on the use of bevacizumab for a tumor with retinal hemorrhage, and it is not known if the tumor with massive retinal or vitreal hemorrhages can safely undergo intravitreous injections of bevacizumab.…”
Section: Discussionmentioning
confidence: 99%
“…A number of studies have demonstrated the utility of conventional ultrasonography (B-mode and color Doppler) in the initial work-up of intraocular metastases (7,17). Differentiating malignant from benign iris masses relies primarily on topographic location, analysis of pattern and degree of vascularity.…”
Section: Discussionmentioning
confidence: 99%
“…There commended dose ranges from 1.25–4 mg, and it has proven to be a safe, effective and relatively easy local treatment for uveal metastasis (17,2631). However, a number of patients with choroidal metastases originating from a variety of primaries, including the lung, colon and breast, experience progressive metastasis despite undergoing IVB treatment (32).…”
Section: Discussionmentioning
confidence: 99%